Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
{
"resourceType" : "Composition",
"id" : "375280",
"meta" : {
"versionId" : "83",
"lastUpdated" : "2025-08-12T18:22:53.937Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/outcome-measure-report"
]
},
"language" : "en",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p class=\"res-header-id\"><b>Generated Narrative: Composition 375280</b></p><a name=\"375280\"> </a><a name=\"hc375280\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 83; Last updated: 2025-08-12 18:22:53+0000; Language: en</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-outcome-measure-report.html\">OutcomeMeasureReport</a></p></div><p><b>Artifact Description</b>: </p><div><p>This is an example of an Outcome Measure Report describing the QUARTET USA Randomized Clinical Trial for the EBM on FHIR Implementation Guide.</p>\n</div><p><b>url</b>: <a href=\"https://fevir.net/resources/Composition/375280\">https://fevir.net/resources/Composition/375280</a></p><p><b>identifier</b>: FEvIR Object Identifier/375280</p><p><b>status</b>: Final</p><p><b>type</b>: <span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 OutcomeMeasureReport}\">Outcome Measure Report</span></p><p><b>date</b>: 2025-08-12 18:22:53+0000</p><p><b>author</b>: Joanne Dehnbostel</p><p><b>title</b>: Outcome Measure Report for QUARTET USA Trial</p><p><b>custodian</b>: <a href=\"Organization-118079.html\">Computable Publishing LLC</a></p><blockquote><p><b>relatesTo</b></p><p><b>type</b>: Part Of</p><p><b>target</b>: <a href=\"Composition-372776.html\">Comparative Evidence Report for QUARTET USA Trial</a></p></blockquote><blockquote><p><b>relatesTo</b></p><p><b>type</b>: Cite As</p><p><b>target</b>: </p><div><p>Outcome Measure Report for QUARTET USA Trial [Database Entry: FHIR Composition Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375280. Revised 2025-08-12. Available at: https://fevir.net/resources/Composition/375280. Computable resource at: https://fevir.net/FLI/DocumentForComposition375280.</p>\n</div></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-description",
"valueMarkdown" : "This is an example of an Outcome Measure Report describing the QUARTET USA Randomized Clinical Trial for the EBM on FHIR Implementation Guide."
}
],
"url" : "https://fevir.net/resources/Composition/375280",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net/FOI",
"value" : "375280",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"status" : "final",
"type" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "OutcomeMeasureReport",
"display" : "OutcomeMeasureReport"
}
],
"text" : "Outcome Measure Report"
},
"date" : "2025-08-12T18:22:53.937Z",
"author" : [
{
"display" : "Joanne Dehnbostel"
}
],
"title" : "Outcome Measure Report for QUARTET USA Trial",
"custodian" : {
🔗 "reference" : "Organization/118079",
"type" : "Organization",
"display" : "Computable Publishing LLC"
},
"relatesTo" : [
{
"type" : "part-of",
"targetReference" : {
🔗 "reference" : "Composition/372776",
"type" : "Composition",
"display" : "Comparative Evidence Report for QUARTET USA Trial"
}
},
{
"type" : "cite-as",
"targetMarkdown" : "Outcome Measure Report for QUARTET USA Trial [Database Entry: FHIR Composition Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375280. Revised 2025-08-12. Available at: https://fevir.net/resources/Composition/375280. Computable resource at: https://fevir.net/FLI/DocumentForComposition375280."
}
],
"section" : [
{
"title" : "Group List",
"code" : {
"text" : "GroupList"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Group/375175",
"type" : "Group",
"display" : "QUARTET USA Trial Quadpill group"
},
{
🔗 "reference" : "Group/375182",
"type" : "Group",
"display" : "QUARTET USA Trial Control Group"
},
{
🔗 "reference" : "EvidenceVariable/375183",
"type" : "EvidenceVariable",
"display" : "GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Results for Systolic blood pressure at 12 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "results",
"display" : "Results"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375185",
"type" : "EvidenceVariable",
"display" : "Systolic blood pressure at 12 weeks"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/375628",
"type" : "Evidence",
"display" : "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group"
},
{
🔗 "reference" : "Evidence/375594",
"type" : "Evidence",
"display" : "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Control Group"
},
{
🔗 "reference" : "Evidence/375907",
"type" : "Evidence",
"display" : "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Results for Diastolic blood pressure at 12 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "results",
"display" : "Results"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375186",
"type" : "EvidenceVariable",
"display" : "Diastolic blood pressure at 12 weeks"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/375629",
"type" : "Evidence",
"display" : "Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group"
},
{
🔗 "reference" : "Evidence/375932",
"type" : "Evidence",
"display" : "Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Control Group"
},
{
🔗 "reference" : "Evidence/375933",
"type" : "Evidence",
"display" : "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Results for Medication Adherence at 12 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "results",
"display" : "Results"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375201",
"type" : "EvidenceVariable",
"display" : "Medication Adherence at 12 weeks"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379723",
"type" : "Evidence",
"display" : "Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Quadpill group"
},
{
🔗 "reference" : "Evidence/379724",
"type" : "Evidence",
"display" : "Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Control Group"
},
{
🔗 "reference" : "Evidence/379725",
"type" : "Evidence",
"display" : "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Results for Hypertension Control at 12 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "results",
"display" : "Results"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375202",
"type" : "EvidenceVariable",
"display" : "Hypertension Control at 12 weeks"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379736",
"type" : "Evidence",
"display" : "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Quadpill group"
},
{
🔗 "reference" : "Evidence/379737",
"type" : "Evidence",
"display" : "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Control Group"
},
{
🔗 "reference" : "Evidence/379738",
"type" : "Evidence",
"display" : "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Results for Add-on Amlodipine at 6 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "results",
"display" : "Results"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375203",
"type" : "EvidenceVariable",
"display" : "Add-on Amlodipine at 6 weeks"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379739",
"type" : "Evidence",
"display" : "Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Quadpill group"
},
{
🔗 "reference" : "Evidence/379740",
"type" : "Evidence",
"display" : "Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Control Group"
},
{
🔗 "reference" : "Evidence/379741",
"type" : "Evidence",
"display" : "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Results for Adverse event free and hypertension control at 12 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "results",
"display" : "Results"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375278",
"type" : "EvidenceVariable",
"display" : "Adverse event free and hypertension control at 12 weeks"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379742",
"type" : "Evidence",
"display" : "Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Quadpill group"
},
{
🔗 "reference" : "Evidence/379743",
"type" : "Evidence",
"display" : "Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Control Group"
},
{
🔗 "reference" : "Evidence/379744",
"type" : "Evidence",
"display" : "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
}
]
}
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot2 based on FHIR 6.0.0-ballot3. Generated 2025-09-04
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change